Loading...
Dernières publications
-
Katarzyna Grychowska, Uriel López-Sánchez, Mathieu Vitalis, Geoffrey Canet, Grzegorz Satała, et al.. Superiority of the Triple-Acting 5-HT 6 R/5-HT 3 R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT 6 R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats. Journal of Medicinal Chemistry, 2023, 66 (21), pp.14928-14947. ⟨10.1021/acs.jmedchem.3c01482⟩. ⟨hal-04235140⟩
-
David T Valenta, Nicolas Ogier, Gary Bradshaw, Audrey S Black, David J Bonnet, et al.. Atheroprotective Potential of Macrophage-Derived Phospholipid Transfer Protein in Low-Density Lipoprotein Receptor-Deficient Mice Is Overcome by Apolipoprotein AI Overexpression. Arteriosclerosis, Thrombosis, and Vascular Biology, 2023, 26 (7), pp.1572 - 1578. ⟨10.1161/01.atv.0000225700.43836.ae⟩. ⟨hal-04203243⟩
-
Sophie Sakkaki, Noemie Cresto, Raphaël Chancel, Maé Jaulmes, Emma Zub, et al.. Dual-Hit: Glyphosate exposure at NOAEL level negatively impacts birth and glia-behavioural measures in heterozygous shank3 mutants. Environment International, 2023, 180, pp.108201. ⟨10.1016/j.envint.2023.108201⟩. ⟨hal-04222342⟩
-
Jennifer Hua, Elvira Garcia de Paco, Nathalie Linck, Tangui Maurice, Catherine Desrumaux, et al.. Microglial P2X4 receptors promote ApoE degradation and contribute to memory deficits in Alzheimer’s disease. Cellular and Molecular Life Sciences, 2023, 80 (5), pp.138. ⟨10.1007/s00018-023-04784-x⟩. ⟨hal-04094016⟩
-
Mattia Difrancesco, Manon Marrot, Eleonora Torre, Pietro Mesirca, Romain Davaze, et al.. Characterization of sinoatrial automaticity in Microcebus murinus to study the effect of aging on cardiac activity and the correlation with longevity. Scientific Reports, 2023, 13 (1), pp.3054. ⟨10.1038/s41598-023-29723-5⟩. ⟨hal-04010411⟩
-
Braham Mezghrani, Lamiaa M.A. Ali, Nicolas Cubedo, Mireille Rossel, Peter Hesemann, et al.. Periodic mesoporous ionosilica nanoparticles for dual cancer therapy: Two-photon excitation siRNA gene silencing in cells and photodynamic therapy in zebrafish embryos. International Journal of Pharmaceutics, 2023, 641, pp.123083. ⟨10.1016/j.ijpharm.2023.123083⟩. ⟨hal-04121650⟩
Collaborations MMDN
Mots clés
Vasopressin
Aggregation
Lemur
Magnetic resonance imaging
Deep brain stimulation
Glial scar
Genetics
Depressive symptoms
IN-VITRO
Behavior
Amyloid fibril
Tauopathies
Amyloid toxicity
Astrocytes
France
Rat
Docosahexaenoic acid
Infection
Healthy life years
Primates
Atherosclerosis
Histology
Mitochondria
Human
Epidemiology
Mortality
Calcium
Chronic subdural hematoma
Huntington’s disease
Amyloid
Phospholipid transfer protein
Neuroscience
Oxytocin
Acetylcholinesterase
Aβ25-35
Detection
Europe
Functional MRI
Glial cells
Amyloid-β peptide
Stem cells
Dietary indices
Frail elderly
Drosophila
Microcebus murinus
Ion channels
Brain
Aged
Spinal cord injury
Alternative Healthy Eating Index
Dementia
Lipoproteins
Aging
Cognitive impairment
Glutamate
Amyotrophic lateral sclerosis
Health expectancy
Centenarians
Mice
Inflammation
Amyloid-β
Zebrafish
Learning and memory
Hypothalamus
Cochlea
HPA axis
Atomic force microscopy AFM
Glucocorticoids
Hsp90
Belgium
80 and over
Transgenic rats
BDNF
Human brain
Disability
Spinal cord injury SCI
Ca2+ signalling
Sigma-1 receptor
ACETYLCHOLINESTERASE
Mouse lemur
High pressure
GSK-3β
Microglia
Prion
Ca2+ oscillations
Alzheimer's disease
Neuroprotection
International comparison
MRI
Butyrylcholinesterase
Rodent
Neurodegeneration
Brain mapping
Depression
Neuroinflammation
Humans
Neurodegenerative diseases
Primate
Proliferation
ER stress